Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Clinical trial NCT02181218 · COMPLETED

Trial details

NCT number: NCT02181218
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous Lymphoma, T-Cell, Peripheral Hodgkin Disease Lymphoma, Large B-Cell, Diffuse

Start date: 2015-02-04
Primary completion: 2019-03-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.